4.0
31. Juli 2024
Aktueller Mitarbeiter, mehr als 5 Jahre
Sydney
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Good company overall with a great mission. Flexible WFH policy depending on your team, department, etc.
Kontras
Projects and deliverables tend to be slower than other companies due to security concerns and regulations of a medical device regulated company. Career progression is hard when you are not into management.